Advertisement

Topics

GeNO LLC Company Profile

22:23 EST 20th February 2019 | BioPortfolio

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and in-home use for potential chronic treatment. GeNO's nitric oxide delivery platforms will be regulated by the FDA as new drugs with their own NDAs. GeNO's platforms have been designated as Combination Products by the FDA Office of Combination Products, with the Division of Cardiovascular and Renal Products designated as the lead reviewer for GeNO's initial IND. GeNO plans to submit a second IND application to FDA later this year to begin evaluation of its ambulatory platform. The company has five US patents with additional patent applications pending.


News Articles [4 Associated News Articles listed on BioPortfolio]

Emerging trends in advanced nano-materials based electrochemical geno-sensors

(Bentham Science Publishers) Advanced nanomaterials indubitably represent one of the most propitious classes of new materials due to their intriguing optical, electronic and redox properties.

Genovis AB GENO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryGenovis AB Genovis develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecul...

Genovis AB GENO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryGenovis AB Genovis develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecul...

Genovis AB GENO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryGenovis AB Genovis develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecul...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Variabilidad genética en regiones codificantes del antígeno de superficie y el dominio de la transcriptasa inversa de la polimerasa del virus de la hepatitis B, Colombia, 2002-2014.

Introducción. Se estima que 240 millones de personas en el mundo tienen infección crónica con el virus de la hepatitis B (HBV). En Colombia, la endemia es variable y circulan diferentes genotipos v...

Human Cardiac Organoids for Disease Modeling.

Human cardiac drug discovery and disease modeling face challenges in recapitulating cellular complexity and animal-to-human translation due to the limitations of conventional 2D cell culture and anima...

Degradation of fibrin-β amyloid co-aggregate: A novel function attributed to ubiquitin.

Human placental extract contains numerous bioactive components and are effective wound healing, antimicrobial and anti-inflammatory agents. During our investigation on the therapeutic potency of human...

Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats.

Although cancer often is referred to as "a disease of the genes," it is indisputable that the (epi)genetic properties of individual cancer cells are highly variable, even within the same tumor. Hence,...

Plant compartment and genetic variation drive microbiome composition in switchgrass roots.

Switchgrass (Panicum virgatum) is a promising biofuel crop native to the United States with genotypes that are adapted to a wide range of distinct ecosystems. Various plants have been shown to undergo...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Pilot Study Evaluating the Safety and Performance of the GeNO Nitrosyl Delivery System for Inhaled Nitric Oxide

This is an open label phase 2 Pilot study designed to evaluate the safety, tolerability and device performance of the GeNO nitrosyl delivery system during right heart catheterization (RHC)...

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

The purpose of this trial is to compare the effectiveness, safety and tolerability of TMC278 given at a dose of 25 mg once daily versus efavirenz (EFV) at a dose of 600 mg once daily, when...

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

The purpose of this trial is to compare the effectiveness, safety and tolerability of TMC278 given at a dose of 25 mg once daily versus efavirenz (EFV) at a dose of 600 mg once daily, when...

Hematopoietic Stem Cell Transplantation and Childhood Leukemia Quality of Life in SIbling DONors

The childhood cancer experience necessarily impacts the entire family. In this context, particular attention should be paid to the donor siblings of hematopoietic stem cells in the context...

A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation

This is a prospective, multicenter open-label single arm trial in which recipients of liver allograft will receive uniform immunosuppressive induction and maintenance regimens. Participant...

Companies [4 Associated Companies listed on BioPortfolio]

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true poten...

Geno Technology

Recent expansions within Geno Technology Inc. have led us to generate new branding to separate our proteomics and genomic products. Over the next few months, our company will be separating into G Bio...

Geno Global Ltd.

GENO is a farmers’ co-operative owned and managed by Norwegian dairy farmers. In 2003 the number of members was approximately 18 000. GENO's main aim is to breed the NRF Norwegian Red in the mo...

Geno Technology, Inc

Nil

More Information about "GeNO LLC" on BioPortfolio

We have published hundreds of GeNO LLC news stories on BioPortfolio along with dozens of GeNO LLC Clinical Trials and PubMed Articles about GeNO LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GeNO LLC Companies in our database. You can also find out about relevant GeNO LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record